CANbridge Pharmaceuticals (HKG:1228) said Glenn Hassan has resigned as the chief financial officer of the company due to personal reasons.
The company's chief executive officer James Qun Xue will temporarily handle the responsibilities of the company's finances along with the finance team until a new CFO is appointed, a Monday filing with the Hong Kong Exchange said.
The biopharmaceutical company's shares closed nearly 12% higher on Monday.
Price (HKD): $0.38, Change: $+0.040, Percent Change: +11.94%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.